ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,505,000 | -42.6% | 113,030 | -63.2% | 0.05% | -45.8% |
| Q3 2021 | $18,307,000 | +6.3% | 307,430 | +21.8% | 0.10% | +6.7% |
| Q2 2021 | $17,216,000 | -0.6% | 252,430 | +1.1% | 0.09% | -8.2% |
| Q1 2021 | $17,322,000 | -17.1% | 249,630 | -8.2% | 0.10% | -22.8% |
| Q4 2020 | $20,885,000 | +19.4% | 271,830 | +16.2% | 0.13% | -0.8% |
| Q3 2020 | $17,496,000 | -35.0% | 233,930 | -45.3% | 0.13% | +12.3% |
| Q2 2020 | $26,934,000 | +654.5% | 427,860 | +403.4% | 0.11% | +48.1% |
| Q1 2020 | $3,570,000 | +12.3% | 85,000 | +21.4% | 0.08% | +40.0% |
| Q4 2019 | $3,179,000 | -0.8% | 70,000 | 0.0% | 0.06% | -15.4% |
| Q3 2019 | $3,204,000 | – | 70,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |